A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer | MicrobiomeTrials← Back to trialsNCT04802759
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2021-06-22Est. Completion: 2029-05-30
Enrollment target: 316 participants Locations- City of Hope, Duarte, California, United States
- City of Hope - Orange County Lennar Foundation Cancer Center, Irvine, California, United States
- University of California, San Francisco (UCSF), San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Santa Monica, California, United States
- Stanford Cancer Institute (SCI), Stanford, California, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Regional Cancer Care Associates LLC (RCCA) - Freehold Location, Freehold, New Jersey, United States
- Regional Cancer Care Associates LLC ? Howell Division, Howell Township, New Jersey, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
- West Cancer Center, Germantown, Tennessee, United States
- Flinders Medical Centre, Bedford Park, South Australia, Australia
- Peninsula Health-Frankston Hospital, Frankston, Victoria, Australia
Other microbiome trials you might be interested in
Triple Negative Breast CancerLocally Advanced Breast CancerRecurrent Breast CancerMetastatic Breast CancerER+ Breast CancerHER2-positive Breast Cancer
This clinical study is aiming to determine the safest doses and schedule for the combination of two drugs named palbocic…
Manchester, United KingdomEst. completion Jul 31, 2026
Breast Cancer
To compare the combination of Ribociclib plus goserelin acetate with hormonal therapy versus combination chemotherapy in…
Peter Maccallum Cancer Centre, Melbourne, Victoria, AustraliaLinear Clinical Research Limited, Nedlands, Western Australia, AustraliaShaare Zedek Medical Center, Jerusalem, Jerusalem, IsraelRambam Medical Center, Haifa, IsraelHadassah Ein Karem Hospital, Jerusalem, IsraelRabin MC, Petah Tikva, IsraelThe Chaim Sheba Medical Center, Ramat Gan, IsraelTel Aviv Sourasky Medical Center, Tel Aviv, IsraelAssuta Medical Centers, Tel Aviv, IsraelNational Cancer Center, Goyang-si, South KoreaSamsung Medical Center, Seoul, South KoreaSeoul National University Hospital, Seoul, South KoreaAsan Medical Center, Seoul, South KoreaSeverance Hospital, Seoul, South KoreaHospital Universitario Vall d Hebron, Barcelona, SpainHospital Universitario Ramón y Cajal, Madrid, SpainCentro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, SpainHospital Clinico Universitario de Valencia, Valencia, SpainCairo, EgyptCompleted Apr 12, 2022